Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education/College of Life Science, Northwest University, Xi'an, China.
Hospital of Xi'an City, Xi'an, China.
Pharmacology. 2018;101(5-6):269-277. doi: 10.1159/000487144. Epub 2018 Mar 2.
In clinical practice, herbal medicines have played an important role in the modulation of drug transporters through the combination of conventional prescription drugs, which necessitates the elucidation of herb-drug interactions. The present study was designed to investigate the inhibitory effects and mechanisms of benzaldehyde, vanillin, muscone, and borneol on P-glycoprotein (P-gp).
The effects of the 4 compounds on the intracellular accumulation of rhodamine-123 (Rho-123) in vinblastine-treated Caco-2 (VB-Caco-2) cells were studied by monitoring fluorescence intensity through a flow cytometry assay, and the effects of these compounds on Rho-123 transport through VB-Caco-2 monolayers and Rho-123 intestinal absorption in the rat everted gut sac were investigated by high-performance liquid chromatography. Moreover, P-gp expression in VB-Caco-2 cells was assessed using flow cytometry and Western blot analysis, and the relative ABCB1 mRNA level was determined by Real-time RT-PCR.
The results showed that benzaldehyde, vanillin, muscone, and borneol significantly increased Rho-123 uptake in VB-Caco-2 cells, increased the absorption rate and apparent permeability coefficient of Rho-123 in rat jejunum and ileum, and decreased the efflux ratio of Rho-123 from 6.52 to less than 2 during transport across VB-Caco-2 cell monolayers. In addition, these compounds reduced the protein and ABCB1 mRNA levels of P-gp in VB-Caco-2 cells.
These data indicate that benzaldehyde, vanillin, muscone and borneol could effectively reverse multidrug resistance via inhibiting the P-gp function and expression pathway. The data provide fodder for further investigation into the interaction between the 4 compounds and other drugs transported by P-gp.
在临床实践中,草药通过与常规处方药联合使用,在调节药物转运体方面发挥了重要作用,这就需要阐明草药-药物相互作用。本研究旨在研究苯甲醛、香草醛、麝香酮和龙脑对 P-糖蛋白(P-gp)的抑制作用及其机制。
通过流式细胞术检测荧光强度研究 4 种化合物对长春碱处理的 Caco-2(VB-Caco-2)细胞中罗丹明 123(Rho-123)细胞内积累的影响,并通过高效液相色谱法研究这些化合物对 Rho-123 通过 VB-Caco-2 单层转运和 Rho-123 在大鼠外翻肠囊中的肠吸收的影响。此外,通过流式细胞术和 Western blot 分析评估 VB-Caco-2 细胞中 P-gp 的表达,并通过 Real-time RT-PCR 测定相对 ABCB1 mRNA 水平。
结果表明,苯甲醛、香草醛、麝香酮和龙脑显著增加 VB-Caco-2 细胞中 Rho-123 的摄取,增加 Rho-123 在大鼠空肠和回肠中的吸收速率和表观渗透系数,并降低 Rho-123 在 VB-Caco-2 细胞单层转运过程中的外排率,从 6.52 降至小于 2。此外,这些化合物降低了 VB-Caco-2 细胞中 P-gp 的蛋白和 ABCB1 mRNA 水平。
这些数据表明,苯甲醛、香草醛、麝香酮和龙脑可通过抑制 P-gp 功能和表达途径有效逆转多药耐药。这些数据为进一步研究 4 种化合物与其他 P-gp 转运药物的相互作用提供了依据。